Fashion
-
Exhibition brings US visitors close to the diverse Chinese culture through world-class photographers' lensDetails
GUANGZHOU,China,Feb. 14,2025-- News report from GDToday. A photo exhibition titled "Nihao,China! See You in Guangdong" was held in Orange County,California,from January 23 to February 12,sho
-
Notice convening the Annual General Meeting of AB ElectroluxDetails
STOCKHOLM,Feb. 14,2025-- The shareholders of ABElectrolux (publ),reg. no. 556009-4178 (the "Company"),are hereby given notice of the Annual General Meeting to be held on Wednesday,March 26,2
-
Aker Horizons ASA: Fourth-quarter results 2024Details
FORNEBU,Norway,Feb. 13,2025-- Aker Horizons ASA (OSE:AKH),a developer of green energy and industry,today announced results for the fourth quarter 2024. Aker Horizons\' net capital employed stood at NO
-
CGS International Successfully Concludes ASEAN Investment Challenge 2024 with Malaysian WinnerDetails
ASEAN Investment Challenge (AIC) 2024 brings together more than 5,000 higher education students for an insightful journey into responsible investing
-
SM C2R (Singapore) and Advanced Lighting Company (ALC) Strengthen Strategic Partnership Through Joint Ownership of SM C2R Arabia to Support Saudi Vision 2030Details
SINGAPORE and RIYADH,Saudi Arabia,Feb. 13,2025-- SM C2R (Singapore),a member of Swan & Maclaren Group,and Advanced Lighting Company (ALC),a leading Saudi-based lighting manufacturer,proudly announ
-
Conrad Xiamen Awarded Four-Star Recognition in the 2025 Forbes Travel GuideDetails
The Only Forbes-Starred Hotel in Xiamen XIAMEN,China,Feb. 13,2025--Conrad Xiamen proudly announces its Four-Star recognition in the 2025 Forbes Travel Guide,making it the only hotel in Xiamen to recei
-
Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Ovarian Cancer of Anti-HER2 Bispecific ADC JSKN003Details
SUZHOU,China,Feb. 13,2025-- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 bi
-
DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic DevelopmentDetails
SEOUL,South Korea,Feb. 13,2025-- DAAN Biotherapeutics,a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies,has signed an exclusive licensing agreement w
-
AI is turbocharging media production and democratizing creativity, but challenges persist for the industry, reveals new MIT Technology Review Insights research reportDetails
Digital media standards underlie every advance CAMBRIDGE,Mass.,Feb. 13,2025-- A new report byMIT Technology Review Insights explores how emerging tech is remaking the media and entertainment industri
-
Altair and LTTS Launch 5G-6G Wireless Center of Excellence to Shape the Future of Telecommunications InnovationDetails
CoE to provide leading 5G-6G capabilities for clients in telecommunications,smart factories,connected vehicles,and healthcare